Lotus Eye Hospital Institute Ltd vs Nexus Surgical And Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Lotus Eye Hospital & Institute Ltd is ₹ 106.5 as of 30 Oct 15:30 . The P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 2533 on March 2026 . This represents a CAGR of 88.83% over 6 yearsThe P/E Ratio of Nexus Surgical and Medicare Ltd changed from 12.3 on March 2021 to 11.9 on March 2026 . This represents a CAGR of -0.55% over 6 years The Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 210.77 crore on March 2026 . This represents a CAGR of 15.86% over 6 yearsThe Market Cap of Nexus Surgical and Medicare Ltd changed from ₹ 1.89 crore on March 2021 to ₹ 8.77 crore on March 2026 . This represents a CAGR of 29.15% over 6 years The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 17.27 crore as compare to the Mar '26 revenue of ₹ 14.09 crore. This represent the growth of 22.57% The revenue of Nexus Surgical and Medicare Ltd for the Jun '26 is ₹ 2.58 crore as compare to the Mar '26 revenue of ₹ 2.07 crore. This represent the growth of 24.64% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 0.95 crore. This represent the growth of 231.58% The ebitda of Nexus Surgical and Medicare Ltd for the Jun '26 is ₹ 0.27 crore as compare to the Mar '26 ebitda of ₹ 0.32 crore. This represent the decline of -15.62% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ 0.61 crore over 9 quarters. This represents a CAGR of -0.72% The net profit of Nexus Surgical and Medicare Ltd changed from ₹ 0.09 crore to ₹ 0.2 crore over 9 quarters. This represents a CAGR of 42.60% The Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Nexus Surgical and Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Lotus Eye Hospital & Institute Ltd

Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
Limited' on 14 March, 1997.
The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

About Nexus Surgical and Medicare Ltd

Nexus Surgical & Medicare Limited was formerly incorporated as Nexus Commodities and Technologies Limited in 1992.
The Company came out with a public issue in Aug.'96 to part-finance the project.
Later, the name of the Company was changed to Nexus Surgical & Medicare Limited in August 2020.
The Company is engaged into trading of medical essentials.
Prior to this, it was promoted by a group of technocrats to manufacture and market premium consumer durables and domestic appliances. The Company is a wholesale dealer dealing in various sizes of disposal syringe (with and without needle) and pouches of various size used for storage of sterilized equipment and materials.

FAQs for the comparison of Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd

Which company has a larger market capitalization, Lotus Eye Hospital & Institute Ltd or Nexus Surgical and Medicare Ltd?

Market cap of Lotus Eye Hospital & Institute Ltd is 221 Cr while Market cap of Nexus Surgical and Medicare Ltd is 11 Cr

What are the key factors driving the stock performance of Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd?

The stock performance of Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd?

As of November 1, 2026, the Lotus Eye Hospital & Institute Ltd stock price is INR ₹106.5. On the other hand, Nexus Surgical and Medicare Ltd stock price is INR ₹20.39.

How do dividend payouts of Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd compare?

To compare the dividend payouts of Lotus Eye Hospital & Institute Ltd and Nexus Surgical and Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.